New radioactive 'Smart Bomb' targets Hard-to-Treat cancers

NCT ID NCT05706129

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study is testing a new way to find and treat several types of advanced solid tumors, including kidney, pancreatic, and colorectal cancers. It uses a special radioactive compound that attaches to a protein found on these cancer cells. The study has multiple parts: first, to see if the imaging agent is safe and can spot tumors; then, to find the best dose of the treatment version; and finally, to check if the treatment shrinks tumors. About 270 adults with cancers that have spread or cannot be removed by surgery will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CANCER (CCRCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HM - Hopital de la Timone

    RECRUITING

    Marseille, 13005, France

  • CHRU de Nancy - Hopitaux de Brabois

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

  • CHU de Grenoble-Alpes, Boulevard de la Chantourne

    RECRUITING

    Grenoble, 38043, France

  • CHU de Nantes

    RECRUITING

    Nantes, 44093, France

  • Centre Georges François Leclerc

    RECRUITING

    Dijon, 21079, France

  • Centre Jean Perrin

    RECRUITING

    Clermont-Ferrand, 63011, France

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69373, France

  • IUCT - Oncopole

    RECRUITING

    Toulouse, 31100, France

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, VIC 3000, Australia

  • UNSW Sydney, St Vincent's Hospital Sydney

    RECRUITING

    Sydney, NSW 2010, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.